ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,409Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 910

$588K Total Retail Price of All Prescriptions

Rank: 117 out of 910

364 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,015 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 534 526 1 1
WARFARIN SODIUM 466 438 2 11
FUROSEMIDE 461 452 3 9
CITALOPRAM HBR 285 268 4 19
DONEPEZIL HCL 276 276 5 32
LISINOPRIL 273 273 6 2
POTASSIUM CHLORIDE 269 269 7 18
OMEPRAZOLE 255 241 8 5
METOPROLOL TARTRATE 239 231 9 7
NAMENDA 215 215 10 57
SIMVASTATIN 201 197 11 3
HYDROCODONE-ACETAMINOPHEN 201 193 S3 11 8
GABAPENTIN 199 190 13 13
AMLODIPINE BESYLATE 188 182 14 4
TRAMADOL HCL 170 170 15 25
KLOR-CON M10 159 159 16 169
PREDNISONE 157 156 17 43
DIVALPROEX SODIUM 151 141 18 73
METOPROLOL SUCCINATE 144 144 19 21
ATENOLOL 140 120 20 10
TRAZODONE HCL 127 127 21 37
ALENDRONATE SODIUM 126 116 22 22
POLYETHYLENE GLYCOL 3350 125 110 23 104
EXELON 123 123 24 181
TAMSULOSIN HCL 118 118 25 29
SERTRALINE HCL 107 107 26 24
ESCITALOPRAM OXALATE 107 107 26 113
MIRTAZAPINE 107 107 26 68
RISPERIDONE 103 103 29 67
PROMETHAZINE HCL 101 99 R 30 129
CARBIDOPA-LEVODOPA 93 93 31 91
CARVEDILOL 93 87 31 36
FLUTICASONE PROPIONATE 87 87 33 23
QUETIAPINE FUMARATE 86 86 34 70
OLANZAPINE 85 83 35 145
METFORMIN HCL 84 71 36 6
LEVETIRACETAM 82 82 37 98
DIGOXIN 81 74 38 64
LOSARTAN POTASSIUM 77 77 39 15
OXYCODONE-ACETAMINOPHEN 70 68 S2 40 31
LIDODERM 70 70 40 164
FAMOTIDINE 69 69 42 101
OXYBUTYNIN CHLORIDE 68 62 43 83
ISOSORBIDE MONONITRATE ER 67 67 44 81
ATORVASTATIN CALCIUM 67 67 44 14
NYSTATIN 63 62 46 184
RANITIDINE HCL 60 60 47 28
DIOVAN 59 50 48 34
CLOPIDOGREL 59 59 48 35
PRAVASTATIN SODIUM 57 34 50 16
ALBUTEROL SULFATE 57 56 50 102
FENTANYL 51 51 S2 52 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.